“Orally Administered Fisetin Reduces the Symptoms of Acute Allergic Asthma in a Preclinical Mouse Model”, Biomed. Res. Ther., vol. 9, no. 3, pp. 4953–4970, Mar. 2022, doi: 10.15419/bmrat.v9i3.731.